RSS   Newsletter   Contact   Advertise with us
Post Online Media

Strongbridge Biopharma adds Jeffrey Sherman to board of directors

Strongbridge BiopharmaStrongbridge Biopharma, a biopharmaceutical company, announced that Jeffrey W. Sherman has been appointed to Strongbridge Biopharma’s board of directors.
Article continues below

READ MORE HMS Holdings names CFO

Dr. Sherman has more than 25 years of research, clinical development, regulatory and commercialization experience within the biopharmaceutical industry.

Since 2009, he has served as chief medical officer and an executive vice president at Horizon Pharma.

He also previously held senior leadership positions at IDM Pharma, Takeda Global Research and Development, NeoPharm, Searle/Pharmacia, Bristol-Myers Squibb, and is a past president of the Drug Information Association (DIA).

Dr. Sherman earned his M.D. from the Rosalind Franklin University of Medicine and Science/The Chicago Medical School.

He completed internship and residency programs at Northwestern University Feinberg School of Medicine, where he currently serves as an adjunct assistant professor, and a fellowship position at the University of California San Francisco.

He received a B.A. in Biology from Lake Forest College.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy